UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time - Urology
Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma | BMC Cancer | Full Text
Recurrence predictors for risk score calculus. | Download Table
PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
Kidney cancer prognosis: Life expectancy, stages, survival rates
Frontiers | T1 Stage Clear Cell Renal Cell Carcinoma: A CT-Based Radiomics Nomogram to Estimate the Risk of Recurrence and Metastasis
The multispeciality approach to the management of localised kidney cancer - The Lancet
EORTC Bladder Cancer Recurrence and Progression Calculator
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer - Journal of Geriatric Oncology
The multispeciality approach to the management of localised kidney cancer - The Lancet
ICUrology :: Investigative and Clinical Urology
a Screenshot of the ACS NSQIP Surgical Risk Calculator individual... | Download Scientific Diagram
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Frontiers | A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma - European Urology
Renal Cell Carcinoma is Treatable and Curable
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients